OMAHA, Neb., July 26, 2022 (GLOBE NEWSWIRE) -- Centese, Inc. announces the first peer-reviewed clinical study on its Thoraguard® digital drainage system for cardiac surgery at Stanford University ...
ClearFlow, Inc., a medical device company based in Irvine, California, announced positive results from a clinical trial published in the peer-reviewed journal Innovations: Technology and Techniques in ...
OMAHA, Neb., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Centese, Inc. announces the results of a newly published peer-reviewed clinical study on its Thoraguard Intelligent Chest Tube Management System for use ...
IRVINE, Calif.--(BUSINESS WIRE)--ClearFlow, Inc., a medical device company based in Irvine, California, has announced positive clinical trial results published in the peer-reviewed Journal of ...
PleuraFlow Active Clearance Technology (ACT; ClearFlow) is a chest drain that incorporates a tube clearance system. It comprises a silicone chest tube and the PleuraFlow clearance apparatus. The ...
Chest wall tumors are uncommon; surgical repair involves both resection of the tumor and reconstruction of the chest structures. Diagnosis of the tumor is performed to determine whether it is benign ...